Content
01/08/2025
Costa Mesa, CA USA
Relief Cardiovascular
completed $12 million Series A Round funding. Investors include
Broadview Ventures (lead), Advent Life Sciences (lead), Heartwork Capital, Pacific Growth Investors.
About
Relief Cardiovascular is a privately held medical device company committed to improving outcomes for patients with heart failure. The company's flagship technology, the Relief System, is a transcatheter smart implant designed to enhance fluid management and improve quality of life for heart failure patients. Relief Cardiovascular was founded and incubated within inQB8 Medical Technologies, LLC.
Startup
Sector:
MedTech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
